Worth Venture Partners, LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 57 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$2,555,329
-54.7%
170,925
-75.0%
1.51%
-56.3%
Q3 2022$5,638,000
+19.0%
685,026
-4.4%
3.45%
+24.0%
Q2 2022$4,736,000
+20.1%
716,436
+1.6%
2.78%
+52.9%
Q1 2022$3,942,000
+43.7%
705,154
+20.5%
1.82%
+34.0%
Q4 2021$2,744,000
-2.3%
585,168
+28.8%
1.36%
+7.6%
Q3 2021$2,808,000454,3641.26%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$23,481,0000.99%
Cormorant Asset Management, LP 1,000,000$5,940,0000.23%
WealthTrust Axiom LLC 22,347$132,0000.06%
SECTORAL ASSET MANAGEMENT INC 100,000$594,0000.05%
Virtu Financial LLC 24,577$146,0000.02%
PDT Partners, LLC 61,839$367,0000.02%
SABBY MANAGEMENT, LLC 26,039$155,0000.02%
MGO ONE SEVEN LLC 10,000$59,0000.01%
WINTON GROUP Ltd 45,208$269,0000.01%
Ancora Advisors LLC 36,350$216,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders